Healthcare Sector Summary:
During Friday’s trade, Cambrex Corporation. (NYSE:CBM), was the top gainer and the most volatile stock of the healthcare sector, and added 27.54% to the share, while it remained 5.32% volatile for the week and 3.47% for the month. Actinium Pharmaceuticals, Inc. (NYSEMKT:ATNM), was among the top loser of the sector, losing -24.45% from the share.
On the other hand, Pfizer Inc. (NYSE:PFE), hits new 52-week high of $33.50, and closed at $33.17, and Pfizer, was also among the most active stock of the session, attaining volume of 34,982,501, while Actinium Pharmaceuticals, Inc. (NYSE:ATNM), hits new 52-week low of $3.61, and settled at $3.77.
Hospira Inc. (NYSE:HSP), showed an unusual incline of volume 16,728,981, as compared to its average volume of 1,871,380 for the last trading session. Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), will release their earning report, before the market open today.
Details about some major gainers from healthcare sector, during Friday’s trade are described below:
Cambrex Corporation. (NYSE:CBM), was the top gainer for Friday’s trade, with shares boost of 27.54% and led the share to close at $30.01, after a life sciences company, declared that it has initiated the second noteworthy expansion of its Charles City, Iowa facility in less than three years. Strong continued growth in demand for the Company’s active pharmaceutical ingredient (API) contract manufacturing capabilities is driving the need for more capacity. The Company anticipates to invest between $45 and $50 million during 2015, counting a state of the art cGMP production facility and related supporting infrastructure. This project is predictable to be accomplished in early 2016 and is designed to allow Cambrex to quickly and efficiently further expand cGMP capacity, as future growth requires.
Cambrex Corporation. (NYSE:CBM), is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics.
Shares of Brookdale Senior Living Inc. (NYSE:BKD), jumped nearly 6.68% and closed at $36.88, soon after the leading operator of senior living communities throughout the United States, issued the statement in response to the press release and white paper issued by Sandell Asset Administration.
Brookdale Senior Living Inc. (NYSE:BKD), is the leading operator of senior living communities throughout the United States. The company is committed to providing senior living solutions primarily within properties that are designed, purpose-built and operated to provide the highest-quality service, care and living accommodations for residents.
IsoRay, Inc. (NYSE:ISR), surged 6.72% to close at $1.43, holding market capitalization of $78.46M. The company attained the volume of 1,115,017, as compared to an average volume of 613,039. Its beta value is -3.65.
A medical technology company and innovator in brachytherapy and medical isotope applications, formerly declared that researchers at the University of Pittsburgh School of Medicine (UPMC) released peer-reviewed study results on Cesium-131 prostate cancer treatment, published in the December issue of Clinical Oncology. The study title is “Five Year Prostate-specific Antigen (PSA) Outcomes after Caesium Prostate Brachytherapy.”
IsoRay, Inc. (NYSE:ISR), through its partner, IsoRay Medical, Inc. is the sole producer of Cesium-131 brachytherapy seeds, which are expanding brachytherapy options throughout the body. Learn more about this innovative Richland, Washington company and explore the many benefits and uses of GliaSite® and Cesium-131 by visiting www.isoray.com.
Shares of the BioScrip Inc. (NASDAQ:BIOS), gained 7.07% & closed at $6.06, as a leading national provider of infusion and home care administration solutions, formerly declared that Hai V. Tran, Senior Vice President, Chief Financial Officer and Treasurer, has tendered his resignation, effective March 27, 2015, in order to pursue other opportunities. The Company has engaged a leading executive search firm to assist identify his replacement.
BioScrip Inc. (NASDAQ:BIOS), is a leading national provider of infusion and home care administration solutions. BioScrip partners with physicians, hospital systems, facilities-based providers, healthcare payors, and pharmaceutical manufacturers to provide patients access to post-acute care services.
Stereotaxis Inc. (NASDAQ:STXS), mounted 23.56% to close at $2.15. The gross margin for the stock is 74.30%, while Operational margin is -23.60%. On the other hand its profit margin is -29.20%. The company volatility for the week is said to be 10.88%, while for the month is 8.91%.
Stereotaxis Inc. (NASDAQ:STXS), designs, manufactures, and markets robotic systems and instruments for the treatment of abnormal heart rhythms in the United States and internationally.
